Geographic · Other long-lived assets
Solothurn, Switzerland — Other long-lived assets
Biogen Solothurn, Switzerland — Other long-lived assets decreased by 2.7% to $2.00B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.7%, from $2.06B to $2.00B.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ4 2025
Rolls up toPP&E (Net)
How to read this metric
An increase suggests significant capital investment or facility expansion in the region, while a decrease may indicate asset depreciation, divestiture, or a shift in manufacturing strategy.
Detailed definition
This metric represents the net book value of non-current, non-financial assets located within the Solothurn, Switzerland...
Peer comparison
Comparable to 'Property, Plant, and Equipment' or 'Non-current assets' reported by geographic region in the financial footnotes of other global pharmaceutical companies.
Metric ID:
biib_segment_solothurn_switzerland_other_long_lived_assetsHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $2.24B | $2.20B | $2.16B | $2.06B | $2.00B |
| QoQ Change | — | -1.7% | -1.9% | -4.6% | -2.7% |
| YoY Change | — | -1.7% | -1.9% | -4.6% | -2.7% |
Range$2.00B – $2.24B
CAGR-10.6%
Avg YoY Growth-2.8%
Median YoY Growth-2.3%
Current Streak4+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Biogen's solothurn, switzerland — other long-lived assets?
- Biogen (BIIB) reported solothurn, switzerland — other long-lived assets of $2.00B in Q4 2025.
- How has Biogen's solothurn, switzerland — other long-lived assets changed year-over-year?
- Biogen's solothurn, switzerland — other long-lived assets decreased by 2.7% year-over-year, from $2.06B to $2.00B.
- What does solothurn, switzerland — other long-lived assets mean?
- The total value of long-term physical assets held by the company in its Solothurn, Switzerland operations.